Clene files prospectus supplement for $6.28M at-the-market equity offering under existing $25M facility

Clene Inc.

On Sept 5, 2025, Clene filed a prospectus supplement to sell up to $6,280,000 of common stock via Canaccord Genuity as placement agent.
Previous sales under the April 28, 2025 equity distribution agreement totaled $3,706,213.
The ATM facility originally covered up to $25,000,000 in aggregate offering price.
Legal opinion from Holland & Knight LLP on share validity was filed as Exhibit 5.1.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.